Results from a prospective, randomised, controlled phase 2 study of fibrinogen concentrate vs cryoprecipitate in pseudomyxoma peritonei surgery

被引:0
|
作者
Roy, A. [1 ]
Sargant, N. [1 ]
Rangarajan, S. [1 ]
Alves, S. [1 ]
Bell, J. [1 ]
Stanford, S. [1 ]
Solomon, C. [2 ]
Kruzhkova, I. [2 ]
Knaub, S. [2 ]
Mohamed, F. [1 ]
机构
[1] Basingstoke & North Hampshire Hosp, Basingstoke, Hants, England
[2] Octapharma AG, Lachen, Switzerland
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
P031
引用
收藏
页码:51 / 51
页数:1
相关论文
共 50 条
  • [41] Apremilast in a Japanese subgroup with Behcet's syndrome: Results from a Phase 3, randomised, double-blind, placebo-controlled study
    Takeno, Mitsuhiro
    Dobashi, Hiroaki
    Tanaka, Yoshiya
    Kono, Hajime
    Sugii, Shouji
    Kishimoto, Mitsumasa
    Cheng, Sue
    McCue, Shannon
    Paris, Maria
    Chen, Mindy
    Ishigatsubo, Yoshiaki
    MODERN RHEUMATOLOGY, 2022, 32 (02) : 413 - 421
  • [42] Is Luteal Phase Estradiol Supplementation Beneficial in Long Agonist IVF-ET Cycles? First Prospective Randomised Controlled Study from Indian Subcontinent
    Kapur, Aishwarya
    Prasad, Sudha
    Kumar, Ashok
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2018, 12 (10) : QC1 - QC3
  • [43] Precision medicine in clinical routine: feasibility results from the multicentric prospective randomized controlled EXALT-2 Study
    Kazianka, L.
    Pemovska, T.
    Rohrbeck, J.
    Kornauth, C.
    Pichler, A.
    Agreiter, C.
    Hauptmann, L.
    Lubowitzki, S.
    Prochazka, K.
    Neumeister, P.
    Schmitt, C.
    Greil, R.
    Willenbacher, W.
    Wolf, D.
    Simonitsch-Klupp, I
    Staber, P.
    ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 : 293 - 294
  • [44] Topical treatment of CIN 2+by cidofovir: Results of a phase II, double-blind, prospective, placebo-controlled study
    Van Pachterbeke, C.
    Bucella, D.
    Rozenberg, S.
    Manigart, Y.
    Gilles, C.
    Larsimont, D.
    Houte, K. Vanden
    Reynders, M.
    Snoeck, R.
    Bossens, M.
    GYNECOLOGIC ONCOLOGY, 2009, 115 (01) : 69 - 74
  • [45] Topline results from prospective, double-masked, placebo controlled phase 2b clinical study evaluating Luminate® in patients with diabetic macular edema
    Kaiser, Peter K.
    Boyer, David S.
    Campochiaro, Peter A.
    Heier, Jeffrey
    Kornfield, Julie
    Kuppermann, Baruch D.
    Quiroz-Mercado, Hugo
    Karageozian, Lisa
    Kutscher, Linda
    Karpus, Mary
    Park, John Y.
    Karageozian, Hampar L.
    Karageozian, Vicken
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
  • [46] Efficacy and safety of incobotulinumtoxinA in the combined treatment of upper facial lines: Results of the first prospective randomised, double-blind, placebo-controlled, multicentre phase III study
    Rzany, Berthold
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 72 (05) : AB16 - AB16
  • [47] Peficitinib, an Oral Janus Kinase Inhibitor, in Moderate-to-severe Ulcerative Colitis: Results From a Randomised, Phase 2 Study
    Sands, Bruce E.
    Sandborn, William J.
    Feagan, Brian G.
    Lichtenstein, Gary R.
    Zhang, Hongyan
    Strauss, Richard
    Szapary, Philippe
    Johanns, Jewel
    Panes, Julian
    Vermeire, Severine
    O'Brien, Christopher D.
    Yang, Zijiang
    Bertelsen, Kirk
    Marano, Colleen
    JOURNAL OF CROHNS & COLITIS, 2018, 12 (10): : 1158 - 1169
  • [48] Effects of dabigatran on the cellular and protein phase of coagulation in patients with coronary artery disease on dual antiplatelet therapy with aspirin and clopidogrel Results from a prospective, randomised, double-blind, placebo-controlled study
    Franchi, Francesco
    Rollini, Fabiana
    Cho, Jung Rae
    King, Rhodri
    Phoenix, Fladia
    Bhatti, Mona
    DeGroat, Christopher
    Tello-Montoliu, Antonio
    Zenni, Martin M.
    Guzman, Luis A.
    Bass, Theodore A.
    Ajjan, Ramzi A.
    Angiolillo, Dominick J.
    THROMBOSIS AND HAEMOSTASIS, 2016, 115 (03) : 622 - 631
  • [49] FLASH GLUCOSE MONITORING WITH THE FREESTYLE LIBRE 2: RESULTS FROM THE FLASH-UK RANDOMISED CONTROLLED TRIAL (ON BEHALF OF THE STUDY GROUP)
    Leelarathna, L.
    Wilmot, E.
    Evans, M.
    Neupane, S.
    Rayman, G.
    Lumley, S.
    Cranston, I.
    Narendran, P.
    Barnard-Kelly, K.
    Elliott, R.
    Gkountouras, G.
    Sutton, C.
    Taxiarchi, P.
    Burns, M.
    Thabit, H.
    Mubita, W.
    Camm, M.
    Kanumilli, N.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2022, 24 : A20 - A21
  • [50] Optimal type 2 diabetes mellitus management: the randomised controlled OPTIMISE benchmarking study: baseline results from six European countries
    Hermans, Michel P.
    Brotons, Carlos
    Elisaf, Moses
    Michel, Georges
    Muls, Erik
    Nobels, Frank
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2013, 20 (06) : 1095 - 1105